Reversal of physiological stress-induced resistance to topoisomerase II inhibitors using an inducible phosphorylation site-deficient mutant of I kappa B alpha.
Mol Pharmacol. 2001 Sep;60(3):559-67.
Mol Pharmacol. 2001.
PMID: 11502888